Boardroom Alpha
Meeting calendar
CRAI · Annual meeting · Thursday, July 17, 2025

Cra International Inc

2 nominees · 3 ballot items.

Election of two Class III directors; advisory vote on executive compensation; ratification of Grant Thornton LLP as independent registered public accountants.

Market cap
$920M
1Y TSR
-21.1%
Board grade
B
Record date
May 23, 2025
Filing
DEF 14A
Meeting concluded · Jul 17, 2025

Follow how the vote landed and what changed on Cra International Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of two Class III directors

    ManagementBoard: FOR

    Election of two Class III directors to a three-year term; nominees are Paul Maleh and Thomas Avery.

  2. 2

    Advisory vote on executive compensation

    ManagementBoard: FOR

    Advisory (non-binding) vote to approve the compensation paid to our named executive officers as disclosed in this proxy statement.

  3. 3

    Ratification of appointment of independent registered public accountants

    ManagementBoard: FOR

    Ratify the appointment by our audit committee of Grant Thornton LLP as our independent registered public accountants for our fiscal year ending January 3, 2026.

Director elections

Nominees on the ballot2

Not independent
Tenure on this board
16.6 yrs
Ownership

Top institutional holders10

Latest 13F quarter
1Neuberger Berman Group LLC5.8%376,744$61M
2FMR LLC5.3%342,015$55M
3TWO SIGMA INVESTMENTS, LP4.4%282,009$46M
4VANGUARD CAPITAL MANAGEMENT LLC4.3%277,040$45M
5BlackRock, Inc.4.2%270,758$44M
6RENAISSANCE TECHNOLOGIES LLC3.5%224,475$36M
7BlackRock, Inc.3.4%218,254$35M
8FMR LLC3.0%193,258$31M
9DIMENSIONAL FUND ADVISORS LP2.8%182,967$30M
10STATE STREET CORP2.2%141,468$23M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Cra International Inc 2025 annual meeting?
Cra International Inc (CRAI) holds its 2025 annual shareholder meeting on Thursday, July 17, 2025.
What is the record date for the Cra International Inc 2025 meeting?
The record date for the Cra International Inc 2025 meeting is Friday, May 23, 2025. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Cra International Inc's 2025 meeting?
The board is presenting 2 director nominees at the Cra International Inc 2025 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Cra International Inc 2025 meeting?
Shareholders will vote on 3 proposals at the Cra International Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer